secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-09-11T12:30:44+00:00
Accession:  0001493152-26-042304
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity furnishes presentation slides for H.C. Wainwright conference; no figures in 8-K body
--------------------------------------------------------------------------------

- Presentation materials (Exhibit 99.1) cover operations and performance; specifics only in the exhibit.
- Materials to be used at H.C. Wainwright 28th Annual Global Investment Conference, Sept 14-16, 2026.
- Report signed by President/CEO Maria Zannes; no financial or operational data disclosed in body.
- Common stock (BIAF) and warrants (BIAFW) trade on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226042304/0001493152-26-042304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226042304/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer